Honorees Francis S. Collins National Institutes of Health (NIH) Kathy Giusti Multiple Myeloma Research Foundation Mark Levin Third Rock Ventures Keith R. Yamamoto UCSFHonoree Elaine R. Mardis Nationwide Children’s HospitalProgram Committee Tal Behar PMWC Intl Geoffrey Ginsburg Duke University School of Medicine Ralph Snyderman Duke UniversityOpening Words Roy Cooper Governor, NC Mary E. Klotman Duke University School of MedicineCurrent Speakers Amy Abernethy Flatiron Health Nancy C. Andrews Duke University Fred Ashbury Viviphi Ltd. Jack Bailey GlaxoSmithKline Todd Bauer Sarah Cannon John Beeler Inivata Jonathan S. Berg UNC-Chapel Hill Anna Berry CellNetix Alexis Borisy Third Rock Ventures Kimberly Blackwell Duke Cancer Institute Chris Boshoff Pfizer Inc. Rebecca Brandes Agilent Technologies Barrett Bready Nabsys Andrew Brooks Bioprocessing Solutions Alliance Robert M. Califf Duke University Chris Callahan Sunquest Lon Cardon GlaxoSmithKline Ballantine Carter Johns Hopkins University Jose Castro-Perez Waters Corporation Jennifer A. Cheeseman Duke University Francis S. Collins National Institutes of Health (NIH) Roy Cooper Governor, NC Chris Cournoyer N-of-One William (Bill) Dalton M2Gen Lawrence David Duke University Benoit Destenaves AstraZeneca Rick Dewey Regeneron Genetics Center William Edenfield Greenville Health System Douglas L. Edgeton North Carolina Biotechnology Center Yaniv Erlich New York Genome Center Stacey Gabriel Broad Institute of MIT and Harvard Charles Gersbach Duke University Geoffrey Ginsburg Duke University School of Medicine Kathy Giusti Multiple Myeloma Research Foundation Stuart Goldberg COTA Inc. Thomas Graf Horizon Blue Cross Matthias Gromeier Duke University Medical Center India Hook-Barnard UCSF Edison Hudson Panaceutics Inc. Christopher Ianelli iSpecimen Frank Ingari Cure Forward Sarah Kerruish Antidote Mark J. Kiel Genomenon Edward S. Kim Levine Cancer Institute Richard Klausner GRAIL Mary E. Klotman Duke University School of Medicine Anthony L. Komaroff Harvard Medical School Paul Lang MedCompGx Mark Levin Third Rock Ventures Stephen Lyle KEW Inc. Howard L. McLeod Moffitt Cancer Center Elaine R. Mardis Nationwide Children’s Hospital John Mikszta BD Technologies Vincent A. Miller Foundation Medicine Jennifer Morrissette Penn Medicine Michael Murray Geisinger Medical Center Zaher Nahle Solve ME/CFS Initiative Lee Newcomer UnitedHealthcare Charles Nicolette Argos Therapeutics John Nicols Codexis John David Nolen Cerner Corporation Boris Pasche Wake Forest Baptist Health Orla O’Hannaidh Womble Carlyle Sandridge & Rice, LLP Nirali Patel University of North Carolina Amrita Pati Roche Sequencing Solutions Eric Perakslis Takeda Pharmaceuticals Brad Perkins Human Longevity Charles M. Perou GeneCentric Diagnostics Kenneth J. Pienta Johns Hopkins University Moira Quinn Charlotte Center City Partners Jeffrey Rogers IBM William (Bill) L. Roper UNC Health Care System Antony Rosen Johns Hopkins Medicine Nicole Russell Stage IV Non-Small Cell Lung Cancer Patient John Ryals Metabolon Eric Schadt Icahn School of Medicine Vandana Shashi Duke University School of Medicine Panna Sharma Cancer Genetics, Inc. Ellen V. Sigal Friends of Cancer Research Daniel Simon Guardant Health Ralph Snyderman Duke University John Strickler Duke Cancer Institute Marty Tenenbaum Cancer Commons Bernadette Tosti QuintilesIMS Victor Weigman Q2 Solutions Jane Wilkinson Broad Genomics Alliance Management Janet Woodcock FDA Christopher W. Woods Duke University Randy Woodson North Carolina State University Keith R. Yamamoto UCSF Scott L. Zeger Johns Hopkins University
